MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 6.030
- -0.060-0.99%
Close Dec 20 16:00 ET
- 6.060
- +0.030+0.50%
Post 20:01 ET
2.36BMarket Cap-3.92P/E (TTM)
6.200High5.930Low19.94MVolume6.000Open6.090Pre Close120.60MTurnover5.60%Turnover RatioLossP/E (Static)390.72MShares15.74052wk High4.49P/B2.15BFloat Cap5.60052wk Low--Dividend TTM356.02MShs Float42.810Historical High--Div YieldTTM4.43%Amplitude4.540Historical Low6.048Avg Price1Lot Size
Recursion Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 18.78%-59.23M | -21.87%-82.22M | -39.53%-102.3M | -244.55%-287.78M | -65.54%-74.08M | -33.70%-72.92M | -9.48%-67.47M | -194.74%-73.32M | 47.34%-83.52M | 26.83%-44.75M |
| Net income from continuing operations | -3.04%-95.84M | -27.13%-97.54M | -39.87%-91.37M | -36.99%-328.07M | -61.75%-93M | -53.89%-93.02M | -17.03%-76.73M | -16.70%-65.33M | -28.42%-239.48M | 11.46%-57.49M |
| Depreciation and amortization | -5.01%7.2M | 61.79%8.97M | 97.88%7.38M | 107.57%24.4M | 135.00%7.55M | 153.53%7.58M | 98.96%5.54M | 34.73%3.73M | 39.87%11.76M | 43.74%3.21M |
| Other non cash items | 4,900.00%8.5M | -95.41%93K | -29.29%1.91M | 33.76%11.45M | 168.88%6.55M | -90.41%170K | -8.20%2.03M | 26.12%2.7M | 108.93%8.56M | 110.54%2.44M |
| Change In working capital | 159.75%2.67M | -1.41%-10.26M | -49.36%-36.45M | -147.90%-50.26M | -1,775.21%-11.27M | 42.54%-4.46M | -6.12%-10.12M | -119.87%-24.4M | 34,387.91%104.92M | 84.82%-601K |
| -Change in receivables | -362.56%-939K | 190.42%736K | -228.08%-1.04M | -387,700.00%-7.76M | -215.25%-6.42M | -105.37%-203K | 54.78%-814K | 95.80%-317K | 99.96%-2K | 306.72%5.57M |
| -Change in payables and accrued expense | -47.78%4.39M | -10.45%4.26M | -88.89%-17.96M | 392.53%8.44M | -50.65%4.78M | 131.91%8.41M | 207.30%4.76M | 27.67%-9.51M | -88.63%1.71M | 442.35%9.69M |
| -Change in other current liabilities | -87.52%-4.7M | 12.47%-2.62M | -55.24%-3.79M | -38.71%-9.86M | 12.41%-1.91M | -18.58%-2.51M | -93.79%-3M | -93.20%-2.44M | ---7.11M | ---2.18M |
| -Change in other working capital | 138.55%3.92M | -14.19%-12.64M | -12.54%-13.66M | -137.23%-41.08M | 43.58%-7.72M | 22.16%-10.16M | -43.01%-11.07M | -108.38%-12.13M | 1,203.20%110.32M | -447.00%-13.68M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 18.78%-59.23M | -21.87%-82.22M | -39.53%-102.3M | -244.55%-287.78M | -65.54%-74.08M | -33.70%-72.92M | -9.48%-67.47M | -194.74%-73.32M | 47.34%-83.52M | 26.83%-44.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,214.70%-4.56M | -103.70%-4.18M | -24.59%-6.65M | -105.29%-10.23M | 68.82%-2.49M | -100.65%-347K | -141.56%-2.05M | -103.73%-5.34M | 171.11%193.25M | 84.73%-7.98M |
| Net PPE purchase and sale | -512.35%-4.56M | 70.21%-1.18M | -28.56%-6.65M | 67.74%-11.96M | 74.09%-2.07M | 90.98%-745K | 75.92%-3.97M | -19.18%-5.18M | 6.88%-37.06M | -78.74%-7.98M |
| Net intangibles purchase and sale | --0 | ---3M | --0 | -99.00%-597K | ---350K | 72.67%-82K | --0 | ---165K | ---300K | --0 |
| Net business purchase and sale | --0 | ---- | ---- | --1.84M | ---71K | --0 | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | -99.79%480K | --0 | ---- | ---- | ---- | 199.42%230.61M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,214.70%-4.56M | -103.70%-4.18M | -24.59%-6.65M | -105.29%-10.23M | 68.82%-2.49M | -100.65%-347K | -141.56%-2.05M | -103.73%-5.34M | 171.11%193.25M | 84.73%-7.98M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -69.38%16.46M | 6,848.03%263.12M | 623.05%13.9M | -9.21%140.13M | -45.23%80.66M | 2,200.60%53.77M | 41.94%3.79M | -7.77%1.92M | -66.34%154.35M | 3,779.24%147.26M |
| Net issuance payments of debt | -9,429.17%-2.29M | -8.33%-26K | -8.33%-26K | -751.11%-766K | -2,917.39%-694K | -4.35%-24K | -9.09%-24K | -9.09%-24K | 99.30%-90K | -9.52%-23K |
| Net common stock issuance | -66.06%16.97M | --261.55M | --10.87M | -10.87%128.09M | -45.66%78.09M | --50M | --0 | --0 | -68.95%143.71M | --143.71M |
| Proceeds from stock option exercised by employees | -53.00%1.78M | -57.96%1.6M | 56.73%3.05M | 19.41%12.81M | -8.63%3.26M | 60.55%3.79M | 41.67%3.81M | -7.60%1.95M | 27.11%10.72M | -6.52%3.57M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -69.38%16.46M | 6,848.03%263.12M | 623.05%13.9M | -9.21%140.13M | -45.23%80.66M | 2,200.60%53.77M | 41.94%3.79M | -7.77%1.92M | -66.34%154.35M | 3,779.24%147.26M |
| Net cash flow | ||||||||||
| Beginning cash position | 15.82%482.75M | -36.53%306.15M | -28.20%401.43M | 89.31%559.11M | -14.56%397.21M | -10.19%416.82M | -6.90%482.38M | 89.31%559.11M | 10.55%295.35M | 14.80%464.89M |
| Current changes in cash | -142.67%-47.33M | 368.85%176.72M | -23.88%-95.06M | -159.79%-157.88M | -95.67%4.09M | -2,600.26%-19.5M | -21.69%-65.73M | -134.44%-76.73M | 837.02%264.07M | 186.25%94.53M |
| Effect of exchange rate changes | 450.43%403K | -165.19%-118K | -10,850.00%-219K | 161.24%188K | 140.39%124K | ---115K | --181K | ---2K | ---307K | ---307K |
| End cash Position | 9.72%435.83M | 15.82%482.75M | -36.53%306.15M | -28.20%401.43M | -28.20%401.43M | -14.56%397.21M | -10.19%416.82M | -6.90%482.38M | 89.31%559.11M | 89.31%559.11M |
| Free cash flow | 13.51%-63.79M | -20.95%-86.4M | -38.52%-108.95M | -148.45%-300.33M | -45.08%-76.49M | -16.87%-73.75M | 8.53%-71.44M | -207.68%-78.66M | 39.07%-120.88M | 19.65%-52.73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
